In mammary tumour stem cells, miR‐16 negatively regulates the expression of wild‐type p53‐induced phosphatase 1 (Wip1), suppresses the self‐renewal and growth of these cells, and sensitizes breast cancer cells to chemotherapeutic agents 41. The gene discussed is PPM1D; the disease is breast carcinoma.